Navigation Links
Low heritability of tinnitus
Date:4/20/2010

The relative importance of genetic factors in tinnitus is low, according to new research from the Norwegian Institute of Public Health. This is the first large population-based study to measure the heritability of tinnitus.

The study looked at prevalence of tinnitus and to what degree it is hereditary. Prevalence of tinnitus was 15.1 percent, which correlates well with findings from other countries.

Tinnitus is a symptom with a variety of underlying causes, such as impaired hearing or exposure to noise and medicines.

Surprisingly low heritability

The new study shows that only 11 percent of the variance of tinnitus in the population are caused by genetic effects, whereas environmental factors account for the remaining 89 percent.

"Such a low heritability is a surprising find because most other diseases studied earlier have been more or less hereditary. We had expected that genetics and the environment would be roughly as important as each other," said Dr Ellen Kvestad at the Division for Mental Health at the Norwegian Institute of Public Health.

The article "Low heritability of tinnitus" was recently published in Archives of Otolaryngology Head and Neck Surgery.

Sub-groups of tinnitus can have higher heredity

In this study it was not possible to differentiate between different clinical forms of tinnitus.

"Our findings do not mean that genes are not important for some forms of tinnitus. Some sub-groups of tinnitus with certain underlying causes can have higher heritability. From our findings alone, resources cannot be allocated to find specific genes that code for tinnitus in general, added Kvestad.


'/>"/>

Contact: Julie Johansen
julie.johansen@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1

Related biology news :

1. The effect of parental education on the heritability of childrens reading disability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... PORTLAND, Oregon and PUNE, India , January 19, ... Market Research, titled, "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - ... 2022, growing at a CAGR of 9.6% from 2016 to 2022. In 2015, ... share owing to high-level security for both public and private sectors. ... ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
(Date:1/13/2017)... Jan. 13, 2017 Sandata Technologies, LLC, ... the homecare industry, including Electronic Visit Verification™ (EVV™), ... Justin Jugs, as Senior Vice President of Product ... years of homecare experience to Sandata, where he ... plans to align Sandata,s suite of solutions with ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/19/2017)... -- Acupath Laboratories, Inc., a leading provider of sub-specialized ... Committee that will guide the company,s vision and strategy ... , a 15-year veteran of the anatomic pathology industry, ... Chief Sales Officer .  Prior to joining Acupath ... leadership roles at several leading lab industry organizations including, ...
(Date:1/18/2017)... Portland, OR (PRWEB) , ... January 18, 2017 ... ... modules that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... Altera Cyclone V E FPGA into a compact business-card sized form factor suitable ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
Breaking Biology Technology: